Gunderson Dettmer has advised Replicate Bioscience. Replicate Bioscience, a clinical-stage biotechnology company specializing in self-replicating RNA (srRNA) therapeutics, has entered into a collaboration agreement with Instituto...
Replicate Bioscience and Instituto Butantan Announce Collaboration for srRNA Rabies Vaccine in Latin America
Novo Nordisk and Replicate Bioscience Enter Strategic Collaboration for RNA-Based Therapies for Metabolic Diseases
Ropes & Gray has advised Novo Nordisk, and Goodwin Procter has advised Replicate Bioscience. Novo Nordisk has entered into a multi-year strategic partnership with Replicate Bioscience...
Replicate Biosciences’ Licensing Agreement with Precision NanoSystems
Gunderson Dettmer advised Replicate Bioscience on the deal. Replicate Bioscience, a San Diego-based biotechnology company, announced its licensing agreement to collaborate with Precision NanoSystems, a developer of...